asa glp-1 agonists RA guidance roundup GLP1 agonists: current and future
Description
Always consult with your healthcare provider before starting or changing any medication
plasma neurofilament light chain and glial fibrillary acidic protein, the fluid markers that track neuroaxonal injury and astrocytic activation, did not improve and in some analyses drifted slightly upward [1]
Communicate with your healthcare provider about dose titration strategies
doi: 10.1016/S0140-6736(14)61933-4
Patient Information Leaflet
Louis This article is republished from The Conversation under a Creative Commons license
